CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications

Menghan Cai1, Xiaoxi Zhou1, Songna Wang1

  • 1School of Pharmacy and Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macau SAR 999078, China.

Insights

CD93, a protein on endothelial cells, is crucial for blood vessel formation and cell clearance. Its abnormal expression in diseases like cancer suggests it

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • CD93 is a transmembrane glycoprotein with C-type lectin-like (CTLD) and EGF-like domains.
  • It is primarily expressed in endothelial cells (ECs).
  • CD93 plays roles in angiogenesis, cell adhesion, migration, and apoptotic cell clearance via ligands like MMRN2 and IGFBP7.

Purpose of the Study:

  • To review the structure, function, and disease mechanisms of CD93.
  • To highlight CD93's role in pathological conditions.
  • To discuss CD93 as a potential therapeutic target.

Main Methods:

  • Literature review of CD93 research.
  • Analysis of CD93 expression in various diseases.
  • Examination of CD93's functional domains and interactions.

Main Results:

  • CD93 regulates key physiological processes in ECs.
  • Aberrant CD93 expression is linked to inflammation, cardiovascular diseases, autoimmune disorders, and cancer.
  • Overexpression in tumor vasculature correlates with poor prognosis.

Conclusions:

  • CD93 is a significant regulator of endothelial cell function and a potential biomarker in disease.
  • Targeting CD93 may improve tumor vascular function and immunotherapy efficacy.
  • Further research is needed for clinical translation.

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K